- Home
- DPRO vs UNCY Comparison
DPRO vs UNCY Comparison
Compare DPRO & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- UNCY
- Stock Information
- Founded
- DPRO 1998
- UNCY 2016
- Country
- DPRO Canada
- UNCY United States
- Employees
- DPRO N/A
- UNCY N/A
- Industry
- DPRO Aerospace
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- DPRO Industrials
- UNCY Health Care
- Exchange
- DPRO Nasdaq
- UNCY Nasdaq
- Market Cap
- DPRO 81.2M
- UNCY 74.2M
- IPO Year
- DPRO N/A
- UNCY 2021
- Fundamental
- Price
- DPRO $5.14
- UNCY $4.04
- Analyst Decision
- DPRO Strong Buy
- UNCY Strong Buy
- Analyst Count
- DPRO 2
- UNCY 5
- Target Price
- DPRO $6.50
- UNCY $55.20
- AVG Volume (30 Days)
- DPRO 1.4M
- UNCY 425.0K
- Earning Date
- DPRO 11-13-2025
- UNCY 11-12-2025
- Dividend Yield
- DPRO N/A
- UNCY N/A
- EPS Growth
- DPRO N/A
- UNCY N/A
- EPS
- DPRO N/A
- UNCY N/A
- Revenue
- DPRO $5,250,872.00
- UNCY N/A
- Revenue This Year
- DPRO $41.59
- UNCY N/A
- Revenue Next Year
- DPRO $132.11
- UNCY $4,481.14
- P/E Ratio
- DPRO N/A
- UNCY N/A
- Revenue Growth
- DPRO 17.08
- UNCY N/A
- 52 Week Low
- DPRO $1.63
- UNCY $3.40
- 52 Week High
- DPRO $7.31
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- DPRO 56.82
- UNCY 41.84
- Support Level
- DPRO $4.28
- UNCY $3.80
- Resistance Level
- DPRO $5.40
- UNCY $4.21
- Average True Range (ATR)
- DPRO 0.32
- UNCY 0.20
- MACD
- DPRO 0.07
- UNCY -0.01
- Stochastic Oscillator
- DPRO 76.79
- UNCY 38.10
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.